TrialBreast cancer research : BCR2014

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer.

Jasmeet Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.